SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera

被引:148
作者
Kuzmina, Alona [1 ]
Khalaila, Yara [2 ]
Voloshin, Olga [2 ]
Keren-Naus, Ayelet [2 ]
Boehm-Cohen, Liora [2 ]
Raviv, Yael [2 ]
Shemer-Avni, Yonat [1 ,2 ]
Rosenberg, Elli [2 ]
Taube, Ran [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel
[2] Soroka Med Ctr, Beer Sheva, Israel
基金
以色列科学基金会;
关键词
RECEPTOR-BINDING DOMAIN; TRANSMISSION;
D O I
10.1016/j.chom.2021.03.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Toward eradicating the COVID-19 pandemic, vaccines that induce high humoral and cellular immune responses are essential. However, SARS-CoV-2 variants have begun to emerge and raise concerns, as they may potentially compromise vaccine efficiency. Here, we monitored neutralization potency of convalescent or Pfizer-BTN162b2 post-vaccination sera against pseudoviruses displaying spike proteins derived from wild-type SARS-CoV-2, or its UK-B.1.1.7 and SA-B.1.351 variants. Compared to convalescent sera, vaccination induces high titers of neutralizing antibodies, which exhibit efficient neutralization potential against pseudovirus carrying wild-type SARS-CoV-2. However, while wild-type and UK-N501Y pseudoviruses were similarly neutralized, those displaying SA-N501Y/K417N/E484K spike mutations moderately resist neutralization. Contribution of single or combined spike mutations to neutralization and infectivity were monitored, highlighting mechanisms by which viral infectivity and neutralization resistance are enhanced by N501Y or E484K/K417N mutations. Our study validates the importance of the Pfizer vaccine but raises concerns regarding its efficacy against specific SARS-CoV-2 circulating variants.
引用
收藏
页码:522 / +
页数:9
相关论文
共 52 条
[1]   A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 [J].
Lundgren J.D. ;
Grund B. ;
Barkauskas C.E. ;
Holland T.L. ;
Gottlieb R.L. ;
Sandkovsky U. ;
Brown S.M. ;
Knowlton K.U. ;
Self W.H. ;
Files D.C. ;
Jain M.K. ;
Benfield T. ;
Bowdish M.E. ;
Leshnower B.G. ;
Baker J.V. ;
Jensen J.-U. ;
Gardner E.M. ;
Ginde A.A. ;
Harris E.S. ;
Johansen I.S. ;
Markowitz N. ;
Matthay M.A. ;
Østergaard L. ;
Chang C.C. ;
Davey V.J. ;
Goodman A. ;
Higgs E.S. ;
Murray D.D. ;
Murray T.A. ;
Paredes R. ;
Parmar M.K.B. ;
Phillips A.N. ;
Reilly C. ;
Sharma S. ;
Dewar R.L. ;
Teitelbaum M. ;
Wentworth D. ;
Cao H. ;
Klekotka P. ;
Babiker A.G. ;
Gelijns A.C. ;
Kan V.L. ;
Polizzotto M.N. ;
Thompson B.T. ;
Lane H.C. ;
Neaton J.D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10) :905-914
[2]   A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection [J].
Alsoussi, Wafaa B. ;
Turner, Jackson S. ;
Case, James B. ;
Zhao, Haiyan ;
Schmitz, Aaron J. ;
Zhou, Julian Q. ;
Chen, Rita E. ;
Lei, Tingting ;
Rizk, Amena A. ;
McIntire, Katherine M. ;
Winkler, Emma S. ;
Fox, Julie M. ;
Kafai, Natasha M. ;
Thackray, Larissa B. ;
Hassan, Ahmed O. ;
Amanat, Fatima ;
Krammer, Florian ;
Watson, Corey T. ;
Kleinstein, Steven H. ;
Fremont, Daved H. ;
Diamond, Michael S. ;
Ellebedy, Ali H. .
JOURNAL OF IMMUNOLOGY, 2020, 205 (04) :915-922
[3]   Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].
Anderson, E. J. ;
Rouphael, N. G. ;
Widge, A. T. ;
Jackson, L. A. ;
Roberts, P. C. ;
Makhene, M. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. B. ;
Flach, B. ;
Lin, B. C. ;
Doria-Rose, N. A. ;
O'Dell, S. ;
Schmidt, S. D. ;
Corbett, K. S. ;
Swanson, P. A., II ;
Padilla, M. ;
Neuzil, K. M. ;
Bennett, H. ;
Leav, B. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Edara, V. V. ;
Floyd, K. ;
Suthar, M. S. ;
Martinez, D. R. ;
Baric, R. ;
Buchanan, W. ;
Luke, C. J. ;
Phadke, V. K. ;
Rostad, C. A. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438
[4]  
Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451
[5]  
Annavajhala M. K., NOVEL SAR COV 2 VARI, DOI [DOI 10.1101/2021.02.23.21252259, 10.1101/2021.02.23.21252259]
[6]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[7]   Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies [J].
Baum, Alina ;
Fulton, Benjamin O. ;
Wloga, Elzbieta ;
Copin, Richard ;
Pascal, Kristen E. ;
Russo, Vincenzo ;
Giordano, Stephanie ;
Lanza, Kathryn ;
Negron, Nicole ;
Ni, Min ;
Wei, Yi ;
Atwal, Gurinder S. ;
Murphy, Andrew J. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Kyratsous, Christos A. .
SCIENCE, 2020, 369 (6506) :1014-+
[8]   Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [J].
Brouwer, Philip J. M. ;
Caniels, Tom G. ;
van der Straten, Karlijn ;
Snitselaar, Jonne L. ;
Aldon, Yoann ;
Bangaru, Sandhya ;
Torres, Jonathan L. ;
Okba, Nisreen M. A. ;
Claireaux, Mathieu ;
Kerster, Gius ;
Bentlage, Arthur E. H. ;
van Haaren, Marlies M. ;
Guerra, Denise ;
Burger, Judith A. ;
Schermer, Edith E. ;
Verheul, Kirsten D. ;
van der Velde, Niels ;
van der Kooi, Alex ;
van Schooten, Jelle ;
van Breemen, Marielle J. ;
Bijl, Tom P. L. ;
Sliepen, Kwinten ;
Aartse, Aafke ;
Derking, Ronald ;
Bontjer, Ilja ;
Kootstra, Neeltje A. ;
Wiersinga, W. Joost ;
Vidarsson, Gestur ;
Haagmans, Bart L. ;
Ward, Andrew B. ;
de Bree, Godelieve J. ;
Sanders, Rogier W. ;
van Gils, Marit J. .
SCIENCE, 2020, 369 (6504) :643-+
[9]  
Burstein D., 2016, BMC PLANT BIOL, V7, DOI [DOI 10.1186/s12870-014-0327-y, 10.1038/ncomms10613]
[10]   Evolution and epidemic spread of SARS-CoV-2 in Brazil [J].
Candido, Darlan S. ;
Claro, Ingra M. ;
de Jesus, Jaqueline G. ;
Souza, William M. ;
Moreira, Filipe R. R. ;
Dellicour, Simon ;
Mellan, Thomas A. ;
du Plessis, Louis ;
Pereira, Rafael H. M. ;
Sales, Flavia C. S. ;
Manuli, Erika R. ;
Theze, Julien ;
Almeida, Luiz ;
Menezes, Mariane T. ;
Voloch, Carolina M. ;
Fumagalli, Marcilio J. ;
Coletti, Thais M. ;
Silva, Camila A. M. ;
Ramundo, Mariana S. ;
Amorim, Mariene R. ;
Hoeltgebaum, Henrique H. ;
Mishra, Swapnil ;
Gill, Mandev S. ;
Carvalho, Luiz M. ;
Buss, Lewis F. ;
Prete Jr, Carlos A. ;
Ashworth, Jordan ;
Nakaya, Helder, I ;
Peixoto, Pedro S. ;
Brady, Oliver J. ;
Nicholls, Samuel M. ;
Tanuri, Amilcar ;
Rossi, Atila D. ;
Braga, Carlos K., V ;
Gerber, Alexandra L. ;
Guimaraes, Ana Paula de C. ;
Gaburo Jr, Nelson ;
Alencar, Cecila Salete ;
Ferreira, Alessandro C. S. ;
Lima, Cristiano X. ;
Levi, Jose Eduardo ;
Granato, Celso ;
Ferreira, Giulia M. ;
Francisco Jr, Ronaldo S. ;
Granja, Fabiana ;
Garcia, Marcia T. ;
Moretti, Maria Luiza ;
Perroud Jr, Mauricio W. ;
Castineiras, Terezinha M. P. P. ;
Lazari, Carolina S. .
SCIENCE, 2020, 369 (6508) :1255-+